Toripalimab Injection (JS001)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Toripalimab Injection (JS001), covering 2021-11-24 to 2021-11-24. Get the full timeline:
Most recent: Clinical Trial Update: A Single-arm, Open-label, Multi-center Phase II Clinical Study to Evaluate the Safety and Efficacy of Toripalimab Injection (JS001) Combined With Bevacizumab as the First-line Therapy for Advanced Hepatocellular Carcinoma (HCC) [Phase 2]